Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025
    • Class of 2024

Search form

Home

News You Need to Know Today
MRI details predict outcomes for dangerous pregnancy complication | CT findings linked with subdural hematoma expansion | More
Wednesday, August 27, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CT findings linked to dangerous subdural hematoma expansion

If left untreated, SDH expansion puts added pressure on the brain, which can lead to damage, impaired neurological function and even death. 

READ MORE >
Head CT
Share on Twitter Share on Facebook Share on Linkedin

CT findings linked to dangerous subdural hematoma expansion

Share on Twitter Share on Facebook Share on Linkedin
Head CT
If left untreated, SDH expansion puts added pressure on the brain, which can lead to damage, impaired neurological function and even death. 
READ MORE >

Machine learning-based model predicts risk of severe pregnancy complication using MRI data

Placenta accreta spectrum is a serious and sometimes deadly perinatal complication. Instances of the condition have risen in recent decades, potentially due to an increase in cesarean deliveries.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Machine learning-based model predicts risk of severe pregnancy complication using MRI data

Share on Twitter Share on Facebook Share on Linkedin
Placenta accreta spectrum is a serious and sometimes deadly perinatal complication. Instances of the condition have risen in recent decades, potentially due to an increase in cesarean deliveries.
READ MORE >

AI-enabled devices lacking validation data prior to FDA clearance more likely to be recalled

FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

AI-enabled devices lacking validation data prior to FDA clearance more likely to be recalled

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.
READ MORE >

In Case You Missed It

Woman dies following severe allergic reaction to CT contrast

The 22-year-old patient was undergoing a computed tomography exam with contrast due to her history of kidney stones.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Woman dies following severe allergic reaction to CT contrast

Share on Twitter Share on Facebook Share on Linkedin
The 22-year-old patient was undergoing a computed tomography exam with contrast due to her history of kidney stones.
READ MORE >

Fluorescent contrast agent noninvasively identifies common skin cancer

When used topically, the agent penetrates the skin and generates a fluorescent signal under the guidance of a fluorescent confocal microscope.

READ MORE >
Fluorescent contrast agent helps diagnose basal cell carcinoma.
Share on Twitter Share on Facebook Share on Linkedin

Fluorescent contrast agent noninvasively identifies common skin cancer

Share on Twitter Share on Facebook Share on Linkedin
Fluorescent contrast agent helps diagnose basal cell carcinoma.
When used topically, the agent penetrates the skin and generates a fluorescent signal under the guidance of a fluorescent confocal microscope.
READ MORE >

Shine working toward U.S. production of Mo-99 for SPECT imaging

Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.

READ MORE >
Molecular Imaging PET and SPECT sign in GE booth ACC23.
Share on Twitter Share on Facebook Share on Linkedin

Shine working toward U.S. production of Mo-99 for SPECT imaging

Share on Twitter Share on Facebook Share on Linkedin
Molecular Imaging PET and SPECT sign in GE booth ACC23.
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
READ MORE >

In Other News

80% of requests for emergency head CT inadequate, single-center study finds

Addressing these inappropriate imaging referrals is necessary to reduce healthcare costs, radiation exposure and pollution, experts write in Insights into Imaging. 

READ MORE >
quality
Share on Twitter Share on Facebook Share on Linkedin

80% of requests for emergency head CT inadequate, single-center study finds

Share on Twitter Share on Facebook Share on Linkedin
quality
Addressing these inappropriate imaging referrals is necessary to reduce healthcare costs, radiation exposure and pollution, experts write in Insights into Imaging. 
READ MORE >

Healthcare AI today: $81M acquisition, Illinois says no to AI therapy, AI glucose cleared, more

FDA clears AI-powered glucose monitoring app. The clearance marks a first for an over-the-counter tool in this category.

READ MORE >
AI patient portal messages personalized care
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: $81M acquisition, Illinois says no to AI therapy, AI glucose cleared, more

Share on Twitter Share on Facebook Share on Linkedin
AI patient portal messages personalized care
FDA clears AI-powered glucose monitoring app. The clearance marks a first for an over-the-counter tool in this category.
READ MORE >

Dispute between Johns Hopkins and UnitedHealthcare pushes patients out-of-network

The two said they’ve been negotiating terms for eight months. Sticking points include denied claims and coverage disputes, with both the insurer and health system pointing fingers.

READ MORE >
UnitedHealth Group - 2
Share on Twitter Share on Facebook Share on Linkedin

Dispute between Johns Hopkins and UnitedHealthcare pushes patients out-of-network

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealth Group - 2
The two said they’ve been negotiating terms for eight months. Sticking points include denied claims and coverage disputes, with both the insurer and health system pointing fingers.
READ MORE >

How nuclear cardiology has transformed care for cardiac amyloidosis

Prem Soman, MD, PhD, explained how early detection and new therapies have been game-changers for the treatment and diagnosis of cardiac amyloidosis.

READ MORE >
Prem Soman, MD, PhD, FACC, FRCP, past president of the American Society of Nuclear Cardiology (ASNC), the Richard S. Caligiuri Endowed Chair in Amyloidosis and Heart Failure, director of the Cardiac Amyloidosis Center, director of nuclear cardiology, and a professor of medicine, University of Pittsburgh Medical Center (UPMC) Heart and Vascular Institute. He is presenting the keynote Mario Verani Memorial Lecture at ASNC 2025, where he will discuss transforming cardiac amyloidosis care.
Share on Twitter Share on Facebook Share on Linkedin

How nuclear cardiology has transformed care for cardiac amyloidosis

Share on Twitter Share on Facebook Share on Linkedin
Prem Soman, MD, PhD, FACC, FRCP, past president of the American Society of Nuclear Cardiology (ASNC), the Richard S. Caligiuri Endowed Chair in Amyloidosis and Heart Failure, director of the Cardiac Amyloidosis Center, director of nuclear cardiology, and a professor of medicine, University of Pittsburgh Medical Center (UPMC) Heart and Vascular Institute. He is presenting the keynote Mario Verani Memorial Lecture at ASNC 2025, where he will discuss transforming cardiac amyloidosis care.
Prem Soman, MD, PhD, explained how early detection and new therapies have been game-changers for the treatment and diagnosis of cardiac amyloidosis.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Best of the Week: MRI links anxiety to brain changes | AI equals rads at prostate cancer detection | 4 deaths prompt US recall
Senate bill would slash radiology spending | MRI links ultraprocessed foods to brain injury | New imaging clinic chain launches
How departments are reducing wait times | Program increases exposure to radiology careers | Gaps in radiation safety knowledge
A warning about BI-RADS | 3-step buyer's guide for radiology AI | IR procedure reduces steroid reliance for KOA | Rad turnover
Radiologists worry of ripple effect after false claims | AI matches rads at prostate cancer detection | Rad Partners scores win
GE HealthCare acquiring radiopharma firm | RP seeks to expand teleradiology services | Telix and ITM merge in $1.65B deal | More
Siemens Healthineers ends general ultrasound sales | More liver cancer patients turning to IR treatments | Anxiety on MRI
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup